1.1 	A bill for an act
1.2 	relating to commerce; modifying cannabis labeling requirements; amending 
1.3 	Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6.
1.4 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.5 	Section 1. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended 
1.6 	to read:
1.7 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
1.8 	cannabis retailer, medical cannabis retailer, or medical cannabis combination business must 
1.9 	provide customers and patients with the following information:
1.10 	(1) factual information specified by the office about impairment effects and the expected 
1.11 	timing of impairment effects, side effects, adverse effects, risks to mental health, risks to 
1.12 	the developing brain, contraindications during pregnancy and breast feeding, addiction 
1.13 	potential, medication interactions, interactions with preexisting medical conditions, and 
1.14 	other health risks supported by science of cannabis flower, cannabis products, lower-potency 
1.15 	hemp edibles, and hemp-derived consumer products;
1.16 	(2) a statement specified by the office that customers and patients must not operate a 
1.17 	motor vehicle or heavy machinery while under the influence of cannabis flower, cannabis 
1.18 	products, lower-potency hemp edibles, and hemp-derived consumer products for eight hours 
1.19 	after consuming edible THC-containing products or for four hours after smoking or vaping 
1.20 	THC-containing products;
2.1 	(3) resources specified by the office that customers and patients may consult to answer 
2.2 	questions about cannabis flower, cannabis products, lower-potency hemp edibles, and 
2.3 	hemp-derived consumer products, and any side effects and adverse effects;
2.4 	(4) contact information for the poison control center and a safety hotline or website for 
2.5 	customers to report and obtain advice about side effects and adverse effects of cannabis 
2.6 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
2.7 	products;
2.8 	(5) substance use disorder treatment options; and
2.9 	(6) any other information specified by the office.
2.10 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical 
2.11 	cannabis retailer may include the information described in paragraph (a) on the label affixed 
2.12 	to the packaging or container of cannabis flower, cannabis products, lower-potency hemp 
2.13 	edibles, and hemp-derived consumer products by:
2.14 	(1) posting the information in the premises of the cannabis microbusiness, cannabis 
2.15 	mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination 
2.16 	business; or
2.17 	(2) providing the information on a separate document or pamphlet provided to customers 
2.18 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
2.19 	hemp edible, or a hemp-derived consumer product.